A multi-centre analysis of the performance of EBUS-TBNA testing for comprehensive molecular profiling in non-small cell lung cancer (NSCLC)

被引：0

作者：

Dyer, Craig ^{[1
]}

Marshall, Kelly ^{[2
]}

Ghosal, Robin ^{[3
]}

Williams, Rhian ^{[1
]}

机构：

[1] Univ Hosp Wales, Cardiff, Wales

[2] Prince Charles Hosp, Merthyr, Wales

[3] Prince Philip Hosp, Llanelli, Wales

来源：

LUNG CANCER | 2024年 / 190卷

关键词：

D O I：

10.1016/j.lungcan.2024.107600

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：1

共 2 条

[1]

[Anonymous], 2022, National Optimal Lung Pathway for Lung Cancer, V2nd

[2] Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group [J].

Mosele, F. ;

Remon, J. ;

Mateo, J. ;

Westphalen, C. B. ;

Barlesi, F. ;

Lolkema, M. P. ;

Normanno, N. ;

Scarpa, A. ;

Robson, M. ;

Meric-Bernstam, F. ;

Wagle, N. ;

Stenzinger, A. ;

Bonastre, J. ;

Bayle, A. ;

Michiels, S. ;

Bieche, I ;

Rouleau, E. ;

Jezdic, S. ;

Douillard, J-Y ;

Reis-Filho, J. S. ;

Dienstmann, R. ;

Andre, F. .

ANNALS OF ONCOLOGY, 2020, 31 (11) :1491-1505

← 1 →